MapLight Therapeutics Q1 EPS $(1.34) Misses $(1.11) Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings MissesNews
MapLight Therapeutics (NASDAQ:MPLT) reported quarterly losses of $(1.34) per share which missed the analyst consensus estimate of $(1.11) by 20.72 percent. This is a 95.43 percent increase over losses of $(29.33) per
MapLight Therapeutics (NASDAQ:MPLT) reported quarterly losses of $(1.34) per share which missed the analyst consensus estimate of $(1.11) by 20.72 percent. This is a 95.43 percent increase over losses of $(29.33) per share from the same period last year.